Preliminary results from the first six patients taking part in a Phase One trial surprised and delighted the Oxford University team.
Although the trial was only designed to test safety and dosages, two men with relatively advanced disease experienced dramatic improvements to their eyesight.
The researchers are now planning a larger Phase II trial that will focus on the therapy's effectiveness.
More top news
Patchy rain affects northern areas of the UK in the next 24 hours. Elsewhere, dry but rather cloudy.
Marjorie and Micheal Cawdery, both 83, were found dead in their house in Portadown, Northern Ireland on Friday.
Ann Myatt, who is contesting Jo Cox's former seat, told a hustings: "We've not yet shot anybody so that's wonderful."